More than 7 million Americans have Alzheimer’s Disease, according to the Alzheimer’s Association. And one in nine people over ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten with a federal deadline to halt off-brand products.

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

Roche, along with Bristol Myers Squibb, Novo Nordisk, AbbVie, Eli Lilly and others, is making inroads into molecular glues to ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are pitted against each other, but only one can be my preferred healthcare stock. Where to invest $1,000 right now? Our analyst team just revealed ...

The test will initially be available at about 50 American research institutes and hospitals that specialise in Alzheimer’s ...

This came drug maker Eli Lilly presented the proposal for grant of permission to import and marketing of the drug ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

A research team at Mount Sinai have developed a risk score they found accurate in predicting Crohn’s disease in patients ...

BioSpace examines the busiest corporate venture capital arms in the pharmaceutical industry. Novo Holdings, which made ...